Sinohealth Technology Holdings Limited (HKG:2361)
Hong Kong
· Delayed Price · Currency is HKD 4.870
-0.150 (-2.99%)
At close: Apr 29, 2026
HKG:2361 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 419.09 | 403.73 | 396.19 | 356.67 | 324.17 | Upgrade
|
| Revenue Growth (YoY) | 3.81% | 1.90% | 11.08% | 10.03% | 60.42% | Upgrade
|
| Cost of Revenue | 170.04 | 170.53 | 172.72 | 197.56 | 131.53 | Upgrade
|
| Gross Profit | 249.05 | 233.2 | 223.47 | 159.11 | 192.64 | Upgrade
|
| Selling, General & Admin | 75.78 | 78.58 | 67.05 | 77.77 | 68.95 | Upgrade
|
| Research & Development | 73.57 | 64.77 | 61.09 | 60.41 | 53.71 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0.02 | Upgrade
|
| Operating Expenses | 157.43 | 152.69 | 145.75 | 140.86 | 125.19 | Upgrade
|
| Operating Income | 91.62 | 80.51 | 77.72 | 18.25 | 67.45 | Upgrade
|
| Interest Expense | -0.44 | -0.62 | -0.64 | -0.41 | -0.53 | Upgrade
|
| Interest & Investment Income | 23.5 | 26.88 | 27.17 | 15.11 | 6.97 | Upgrade
|
| Earnings From Equity Investments | -0.47 | - | - | - | -0.42 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 4.86 | 2.29 | 9.53 | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -8.75 | 8.46 | 4.19 | 11.44 | 16.1 | Upgrade
|
| EBT Excluding Unusual Items | 105.47 | 120.09 | 110.73 | 53.92 | 89.61 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.04 | 4.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | - | - | 0.52 | - | Upgrade
|
| Other Unusual Items | - | 0.06 | 0.01 | - | 1.11 | Upgrade
|
| Pretax Income | 105.53 | 120.15 | 110.74 | 54.47 | 95.53 | Upgrade
|
| Income Tax Expense | 11.03 | 8.33 | 9.8 | 0.26 | 23.55 | Upgrade
|
| Earnings From Continuing Operations | 94.5 | 111.82 | 100.94 | 54.21 | 71.98 | Upgrade
|
| Minority Interest in Earnings | -1.06 | -1.17 | 1.09 | 1.55 | 6.84 | Upgrade
|
| Net Income | 93.44 | 110.65 | 102.03 | 55.76 | 78.81 | Upgrade
|
| Net Income to Common | 93.44 | 110.65 | 102.03 | 55.76 | 78.81 | Upgrade
|
| Net Income Growth | -15.55% | 8.45% | 82.99% | -29.25% | 16.03% | Upgrade
|
| Shares Outstanding (Basic) | 452 | 410 | 426 | 411 | 373 | Upgrade
|
| Shares Outstanding (Diluted) | 452 | 410 | 426 | 411 | 373 | Upgrade
|
| Shares Change (YoY) | 10.13% | -3.74% | 3.76% | 10.06% | - | Upgrade
|
| EPS (Basic) | 0.21 | 0.27 | 0.24 | 0.14 | 0.21 | Upgrade
|
| EPS (Diluted) | 0.21 | 0.27 | 0.24 | 0.14 | 0.21 | Upgrade
|
| EPS Growth | -23.32% | 12.65% | 76.35% | -35.72% | - | Upgrade
|
| Free Cash Flow | - | 89.43 | 75.94 | 29.78 | 58.14 | Upgrade
|
| Free Cash Flow Per Share | - | 0.22 | 0.18 | 0.07 | 0.16 | Upgrade
|
| Dividend Per Share | 0.064 | 0.113 | 0.066 | 0.035 | - | Upgrade
|
| Dividend Growth | -43.26% | 71.35% | 86.93% | - | - | Upgrade
|
| Gross Margin | 59.43% | 57.76% | 56.41% | 44.61% | 59.43% | Upgrade
|
| Operating Margin | 21.86% | 19.94% | 19.62% | 5.12% | 20.81% | Upgrade
|
| Profit Margin | 22.30% | 27.41% | 25.75% | 15.63% | 24.31% | Upgrade
|
| Free Cash Flow Margin | - | 22.15% | 19.17% | 8.35% | 17.94% | Upgrade
|
| EBITDA | 94.26 | 83.15 | 80.15 | 20.91 | 69.53 | Upgrade
|
| EBITDA Margin | 22.49% | 20.59% | 20.23% | 5.86% | 21.45% | Upgrade
|
| D&A For EBITDA | 2.64 | 2.64 | 2.43 | 2.66 | 2.08 | Upgrade
|
| EBIT | 91.62 | 80.51 | 77.72 | 18.25 | 67.45 | Upgrade
|
| EBIT Margin | 21.86% | 19.94% | 19.62% | 5.12% | 20.81% | Upgrade
|
| Effective Tax Rate | 10.45% | 6.93% | 8.85% | 0.48% | 24.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.